MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Community

Home
Community
muscles

MS: Many Stories – From the MStranslate Community

MStranslate
February 26, 2017
Community, Exercise, Lifestyle, MS: Many Stories
Welcome to part 3 of a series of articles being written by MStranslate community member, Andrew.  You may remember Andrew from a video we featured in late 2016, introducing the potential benefits of pilates...
Fatigue

MS: Many Stories – From the MStranslate Community

MStranslate
January 28, 2017
Community, Fatigue, MS: Many Stories, Symptoms
Welcome to part 2 of a series of articles being written by MStranslate community member, Andrew.  You may recognise Andrew from a video we featured in late 2016, introducing the potential benefits of pilates...
pilates

MS: Many Stories – From the MStranslate Community

MStranslate
January 24, 2017
Community, MS: Many Stories
Welcome to part 1 of a series of articles being written by MStranslate community member, Andrew.  You may recognise Andrew from a video we featured in late 2016, introducing the potential benefits of pilates...
MS Many Stories

MS: Many Stories – From the MStranslate Community

MStranslate
December 5, 2016
Community, MS: Many Stories
Whilst many people realise that exercise has benefits for people with multiple sclerosis (MS), they often don't know where to begin.  In this new instalment of our MS: Many Stories series, we meet Andrew,...
MS Many Stories

MS: Many Stories – From the MStranslate Community

MStranslate
October 12, 2016
Community, MS: Many Stories
1 Comment
Our latest MS: Many Stories feature is the second instalment in a series being written by Toni, a regular MStranslate contributor and member of our local MS community here in Melbourne, Australia.  To...
MS Many Stories

MS: Many Stories – From the MStranslate Community

MStranslate
August 27, 2016
Community, MS: Many Stories
2 Comments
As there is no universal experience of living with multiple sclerosis (MS), MStranslate has always placed a strong focus on sharing personal experiences of living with the condition.  This commitment has lead...
Q&A

Upcoming MS Researcher Q&A Announcement

MStranslate
July 12, 2016
Community, Q&A, Videos
We love providing the opportunity for members of our community to interact directly with MS researchers from around the world. Whilst our Google Hangouts have been really well received in the past, we know...
New Zealand

MStranslate Presents at MS Research Days in New Zealand

MStranslate
June 3, 2016
Community, Presentations, Research
Between May 20 and 22, 2016, MStranslate was invited to participate in and present at two research days organised for the local multiple sclerosis (MS) communities in both Auckland and Christchurch, New...

What I believe – by Brett Drummond

MStranslate
March 16, 2016
Collaboration, Community, MStranslate
2 Comments
Whenever I talk to people about MStranslate, the first question I receive (almost without fail) is why MS? Why do we do this? There is an assumption from people that I either have MS or have a personal...

Embracing Crowdfunding to Grow MStranslate

MStranslate
March 7, 2016
Community, Conferences, Research
At MStranslate, we pride ourselves on the quality of science communication that we provide to the international multiple sclerosis community. We believe that one of the aspects that makes us truly unique is...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.